Veritas Pharma Inc. has announced appointment of Mr. Yari Nieken as a director of the company. Mr. Nieken replaces Dr. Dom Spina who sadly passed away in December of 2016. Mr. Nieken has a wide range of public company and capital market experience. He is Founder and President of Foremost Capital Inc. an Exempt Market Dealer. He is currently a director of Marapharm Ventures Inc. and has served on the boards of several public and private issuers including PUF Ventures (President & CEO), Lexagene Holdings Inc. (Director), Duport Capital Ltd. (Director).